Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Viking Therapeutics, Inc. - Common Stock
(NQ:
VKTX
)
33.55
-1.98 (-5.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking
June 29, 2025
Timing matters with biotech stocks; these three companies offer distinct risk-reward profiles but have upcoming catalysts that could redefine their value
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Why This Weight Loss Drug Company's Stock Surged Today
↗
June 26, 2025
Via
The Motley Fool
3 Growth Stocks I'm Loading Up On
↗
June 26, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Government
Why Viking Therapeutics, 67% Off Its Recent Highs, Could Still Have An Edge In Obesity
↗
June 25, 2025
The company just initiated two Phase 3 studies of its weekly under-the-skin shot to stoke weight loss.
Via
Investor's Business Daily
What's Going On With Viking Therapeutics Stock On Wednesday?
↗
June 25, 2025
Viking Therapeutics begins Phase 3 trials for VK2735, testing weekly injections in over 5,000 adults with obesity or type 2 diabetes over 78 weeks.
Via
Benzinga
My 5 Favorite Dirt Cheap Stocks to Buy Right Now
↗
June 24, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
World Trade
Amgen Expands Development Plans For Highly Anticipated Obesity Drug
↗
June 23, 2025
Amgen is expanding its plans for weight-loss drug, MariTide, with a trio of upcoming Phase 3 studies.
Via
Investor's Business Daily
2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts
↗
June 21, 2025
Via
The Motley Fool
Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.
↗
June 18, 2025
Via
The Motley Fool
Are These 2 High-Flying Growth Stocks Still Worth Buying After Recent Pullbacks?
↗
June 16, 2025
Via
The Motley Fool
Topics
Government
10 Health Care Stocks Whale Activity In Today's Session
↗
June 10, 2025
Via
Benzinga
1 Stock Down 34% This Year to Buy and Hold
↗
June 08, 2025
Via
The Motley Fool
Could Viking Therapeutics Become the Next Eli Lilly?
↗
June 02, 2025
Via
The Motley Fool
3 Best Growth Stocks to Buy in June
↗
June 02, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Government
Better Weight Loss Stock: Amgen or Viking Therapeutics?
↗
May 22, 2025
Via
The Motley Fool
Why Viking Therapeutics Stock Bumped 3% Higher Today
↗
May 16, 2025
Via
The Motley Fool
Novo Nordisk Sheds 4% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price
↗
May 16, 2025
Novo Nordisk said Friday it will replace its CEO, citing a sharp tumble for Novo shares amid growing competition.
Via
Investor's Business Daily
Why Weight-Loss Developer Stocks Tumbled on Tuesday
↗
May 13, 2025
Via
The Motley Fool
Topics
Government
2 Monster Stocks in the Making to Buy Now and Hold for 10 Years
↗
May 13, 2025
Via
The Motley Fool
3 Monster Stocks in the Making
↗
May 11, 2025
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
↗
May 09, 2025
Via
Benzinga
Down Nearly 20%: Should You Buy the Dip on Eli Lilly?
↗
May 08, 2025
Via
The Motley Fool
Topics
Earnings
Government
World Trade
Why Viking Therapeutics Stock Surged Nearly 20% Higher in April
↗
May 06, 2025
Via
The Motley Fool
Why Viking Therapeutics Stock Was Victorious This Week
↗
May 02, 2025
Via
The Motley Fool
Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday
↗
May 02, 2025
GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock investors.
Via
The Motley Fool
Topics
World Trade
Is Novo Nordisk Stock a Buy?
↗
May 02, 2025
Via
The Motley Fool
Where Will Viking Therapeutics Be in 3 Years?
↗
May 02, 2025
Viking's leading drug candidate could be a blockbuster in the weight loss market, which experts believe could grow to $150 billion over the coming years.
Via
The Motley Fool
Topics
Bankruptcy
1 Beaten-Down Stock to Buy and Hold for 10 Years
↗
May 01, 2025
Via
The Motley Fool
Topics
Economy
Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?
↗
April 30, 2025
Via
The Motley Fool
Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain
↗
April 30, 2025
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
